We have detected that you are using Internet Explorer to visit this website. Internet Explorer is now being phased out by Microsoft. As a result, NHS Digital no longer supports any version of Internet Explorer for our web-based products, as it involves considerable extra effort and expense, which cannot be justified from public funds. Some features on this site will not work. You should use a modern browser such as Edge, Chrome, Firefox, or Safari. If you have difficulty installing or accessing a different browser, contact your IT support team.
Prescribing for Diabetes in England - 2006/07 to 2016/17Official statistics
- Publication Date:
- 1 Aug 2017
- Geographic Coverage:
- Geographical Granularity:
- Clinical Commissioning Groups
- Date Range:
- 01 Apr 2006 to 31 Mar 2017
Prescribing for Diabetes reports on and examines prescribing trends on medicines prescribed in primary care in England for the treatment and monitoring of diabetes during the period April 2006 to March 2017.
Diabetes is a high profile clinical area, as the prevalence is increasing and costs associated with treating patients with diabetes are also increasing.
- Drugs used in diabetes (British National Formulary (BNF) section 6.1) now make up 11.0 per cent of total primary care net ingredient costs (NIC) and 4.7 per cent of prescription items.
- In the financial year 2016/17 there were 52.0 million items prescribed for diabetes at a total net ingredient cost of £983.7 million. Up from 28.9 million prescription items and £572.4 million in 2006/07.
- Antidiabetic drugs (BNF section 6.1.2) make up 45.1 per cent of the total £983.7 million net ingredient cost of drugs used in diabetes and accounts for 72.0 per cent of prescription items for all diabetes prescribing.